These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 12460096)

  • 21. Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae.
    Cheng JW; Rivera NG
    Ann Pharmacother; 1998 Dec; 32(12):1310-6. PubMed ID: 9876813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.
    Girard SE; Temesgen Z
    Expert Opin Pharmacother; 2001 May; 2(5):765-72. PubMed ID: 11336621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia pneumoniae and vascular disease.
    Gibbs RG; Carey N; Davies AH
    Br J Surg; 1998 Sep; 85(9):1191-7. PubMed ID: 9752857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydia pneumoniae and coronary heart disease.
    Carlisle SS; Nahata MC
    Ann Pharmacother; 1999 May; 33(5):615-22. PubMed ID: 10369627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis].
    Grabczewska Z; Nartowicz E
    Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae.
    Song YG; Kwon HM; Kim JM; Hong BK; Kim DS; Huh AJ; Chang KH; Kim HY; Kang TS; Lee BK; Choi DH; Jang YS; Kim HS
    Yonsei Med J; 2000 Jun; 41(3):319-27. PubMed ID: 10957885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydia pneumoniae, strain TWAR and atherosclerosis.
    Grayston JT; Kuo CC; Campbell LA; Benditt EP
    Eur Heart J; 1993 Dec; 14 Suppl K():66-71. PubMed ID: 8131792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia pneumoniae and vascular disease: an update.
    Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C
    J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
    Kuo C; Campbell LA
    Mol Med Today; 1998 Oct; 4(10):426-30. PubMed ID: 9793930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic therapy in coronary heart disease--where do we currently stand?
    Anand V; Gupta S
    Cardiovasc Drugs Ther; 2001; 15(3):209-10. PubMed ID: 11713887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection and atherosclerosis: emerging mechanistic paradigms.
    Epstein SE; Zhou YF; Zhu J
    Circulation; 1999 Jul; 100(4):e20-8. PubMed ID: 10421626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?].
    Fudal M; Wilczewski P
    Wiad Lek; 2004; 57(3-4):151-5. PubMed ID: 15307523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment.
    Ewald PW; Cochran GM
    J Infect Dis; 2000 Jun; 181 Suppl 3():S394-401. PubMed ID: 10839723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atherosclerosis--a chronic infectious disease caused by Chlamydia pneumoniae].
    Stille W; Stephen C
    Versicherungsmedizin; 1999 Mar; 51(1):12-7. PubMed ID: 10200611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.